2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
18
Phase NA
2
Phase 2
2
Phase 1/2
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
3856
Neoplasms
2988
Prostatic Neoplasms
1751
Colorectal Neoplasms
1426
Lung Neoplasms
1328
Motor Activity
802
Head and Neck Neoplasms
683
Pancreatic Neoplasms
663
Colonic Neoplasms
655
Uterine Cervical Neoplasms
648
Carcinoma, Non-Small-Cell Lung
629
Carcinoma, Hepatocellular
628
Rectal Neoplasms
569
Stomach Neoplasms
544
Brain Neoplasms
483
Ovarian Neoplasms
438
Anxiety Disorders
419
Pain
418
Neoplasm Metastasis
385
Esophageal Neoplasms
384
Polycystic Ovary Syndrome
374
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Urinary Bladder Neoplasms
351
Fatigue
339
Melanoma
322
Multiple Myeloma
321
Lymphoma
305
Depression
305
Endometrial Neoplasms
289
Liver Neoplasms
279
Interventions
Immune Checkpoint Inhibitors
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Solid Cancers
×
Clear all
NCT07427186
2026-02-25
MINER2
Institut Claudius Regaud
Phase NA
Not yet recruiting
600 enrolled
NCT03514368
2026-02-19
MINER
Institut Claudius Regaud
Phase NA
Recruiting
770 enrolled